Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk

Clinical trial NCT06557057 · RECRUITING

Trial details

NCT number: NCT06557057
Sponsor: Mayo Clinic
Status: RECRUITING
Study type: OBSERVATIONAL

HER2-Positive Breast Carcinoma

Start date: 2023-11-16
Primary completion: 2026-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.